Raffles Medical's Cash Position Leaves Room for M&A -- Market Talk

Dow Jones

Yesterday

0553 GMT - Raffles Medical's strong net cash position leaves room for potential mergers and acquisitions, says its bull at CGS International. The Singapore hospital operator's net cash, excluding lease liabilities, was S$261.1 million in 2025, says analyst Tay Wee Kuang in a note. This cash also supports the sustainability of its final and total dividend per share of 3.0 Singapore cents, which offers a dividend yield of around 2.8%, above that of regional peers, he says. The analyst trims his earnings-per-share estimates for 2026-2027 by 0.6%-1.2%, citing a projected decline in finance income. CGSI trims its target price for the stock to S$1.20 from S$1.23 and retains its add rating. Shares drop 1.9% to S$1.05. (megan.cheah@wsj.com)

(END) Dow Jones Newswires

February 25, 2026 00:53 ET (05:53 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2614772032"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2614772032\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2614772032?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-25 13:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2614772032","market":"sh","top_or_hot":-1,"title":"Raffles Medical's Cash Position Leaves Room for M&A -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0553 GMT - Raffles Medical's strong net cash position leaves room for potential mergers and acquisitions, says its bull at CGS International. The Singapore hospital operator's net cash, excluding lease liabilities, was S$261.1 million in 2025, says analyst Tay Wee Kuang in a note. This cash also supports the sustainability of its final and total dividend per share of 3.0 Singapore cents, which offers a dividend yield of around 2.8%, above that of regional peers, he says. The analyst trims his earnings-per-share estimates for 2026-2027 by 0.6%-1.2%, citing a projected decline in finance income. CGSI trims its target price for the stock to S$1.20 from S$1.23 and retains its add rating. Shares drop 1.9% to S$1.05. (megan.cheah@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 25, 2026 00:53 ET (05:53 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Raffles Medical's Cash Position Leaves Room for M&A -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRaffles Medical's Cash Position Leaves Room for M&A -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-02-25 13:53</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0553 GMT - Raffles Medical's strong net cash position leaves room for potential mergers and acquisitions, says its bull at CGS International. The Singapore hospital operator's net cash, excluding lease liabilities, was S$261.1 million in 2025, says analyst Tay Wee Kuang in a note. This cash also supports the sustainability of its final and total dividend per share of 3.0 Singapore cents, which offers a dividend yield of around 2.8%, above that of regional peers, he says. The analyst trims his earnings-per-share estimates for 2026-2027 by 0.6%-1.2%, citing a projected decline in finance income. CGSI trims its target price for the stock to S$1.20 from S$1.23 and retains its add rating. Shares drop 1.9% to S$1.05. (megan.cheah@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 25, 2026 00:53 ET (05:53 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK6511","symbol_name":"医疗保健服务概念","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2614772032","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2614772032","pubTimestamp":1771998780,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0553 GMT - Raffles Medical's strong net cash position leaves room for potential mergers and acquisitions, says its bull at CGS International. The Singapore hospital operator's net cash, excluding lease liabilities, was S$261.1 million in 2025, says analyst Tay Wee Kuang in a note. This cash also supports the sustainability of its final and total dividend per share of 3.0 Singapore cents, which offers a dividend yield of around 2.8%, above that of regional peers, he says. The analyst trims his earnings-per-share estimates for 2026-2027 by 0.6%-1.2%, citing a projected decline in finance income. CGSI trims its target price for the stock to S$1.20 from S$1.23 and retains its add rating. Shares drop 1.9% to S$1.05. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK6511":"医疗保健服务概念","BK6092":"保健护理机构","BSL.SI":"莱佛士医疗"},"translate_title":"莱佛士医疗的现金状况为并购留下了空间——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BSL.SI":1.5},"content_text":"0553 GMT - Raffles Medical's strong net cash position leaves room for potential mergers and acquisitions, says its bull at CGS International. The Singapore hospital operator's net cash, excluding lease liabilities, was S$261.1 million in 2025, says analyst Tay Wee Kuang in a note. This cash also supports the sustainability of its final and total dividend per share of 3.0 Singapore cents, which offers a dividend yield of around 2.8%, above that of regional peers, he says. The analyst trims his earnings-per-share estimates for 2026-2027 by 0.6%-1.2%, citing a projected decline in finance income. CGSI trims its target price for the stock to S$1.20 from S$1.23 and retains its add rating. Shares drop 1.9% to S$1.05. (megan.cheah@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 25, 2026 00:53 ET (05:53 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}